Carfizome 60mg Injection (Carfilzomib) – Long Product Description

Carfizome 60mg Injection (Carfilzomib) is a prescription oncology medicine manufactured by Intas Pharmaceuticals Ltd. It is used in the treatment of multiple myeloma, a type of blood cancer that affects plasma cells in the bone marrow. Carfizome contains Carfilzomib 60mg, a second-generation proteasome inhibitor that helps destroy cancer cells by disrupting their protein recycling process. This targeted mechanism slows the progression of the disease and improves treatment outcomes in patients with relapsed or refractory multiple myeloma who have received one or more prior therapies.

Each pack of Carfizome 60mg Injection contains 1 sterile vial of lyophilized powder for intravenous administration. The medicine must be reconstituted and administered only by qualified healthcare professionals in a hospital or specialized oncology center. Treatment is typically given as part of a combination regimen with medicines such as Dexamethasone, Lenalidomide, or Daratumumab, depending on the patient’s clinical condition and the oncologist’s treatment plan.

How Carfizome 60mg Injection Works

Carfilzomib works by selectively inhibiting the 20S proteasome, an enzyme complex responsible for breaking down damaged or unnecessary proteins inside cells. Multiple myeloma cells depend heavily on this protein recycling system for survival. By blocking proteasome activity, Carfizome causes toxic proteins to accumulate inside cancer cells, triggering programmed cell death (apoptosis) while limiting the growth and spread of the disease.

Because of its targeted mechanism of action, Carfilzomib has become an important treatment option for patients whose multiple myeloma has returned after previous therapies or has become resistant to standard treatment.

Uses of Carfizome 60mg Injection

Carfizome 60mg Injection is prescribed for:

• Treatment of relapsed multiple myeloma
• Treatment of refractory multiple myeloma
• Combination therapy with other anti-myeloma medicines
• Patients who have received one or more previous cancer treatments

The treatment schedule and dosage are determined by the oncologist based on the patient’s body surface area, kidney function, overall health, and response to therapy.

Benefits of Carfizome 60mg Injection

Carfizome offers several important clinical benefits for eligible patients, including:

• Helps control the progression of multiple myeloma.
• Targets cancer cells with a highly selective mechanism.
• May improve progression-free survival when used in combination therapy.
• Suitable for patients with relapsed or treatment-resistant disease.
• Can be combined with modern targeted therapies and corticosteroids.
• Manufactured by Intas Pharmaceuticals, a globally recognized pharmaceutical company.

Administration

Carfizome 60mg Injection is administered as an intravenous infusion under strict medical supervision. Patients usually receive adequate hydration before and after infusion to reduce the risk of kidney complications. Regular blood tests, heart function assessments, liver function tests, and kidney monitoring are recommended throughout treatment.

Patients should never attempt to administer this medicine at home.

Possible Side Effects

Like all cancer medicines, Carfizome may cause side effects. Not every patient experiences the same reactions.

Common side effects include:

• Fatigue
• Fever
• Nausea and vomiting
• Diarrhea
• Shortness of breath
• Low platelet count
• Anemia
• Low white blood cell count
• Headache
• Loss of appetite
• Constipation

Serious side effects may include:

• Heart failure
• High blood pressure
• Kidney impairment
• Liver problems
• Serious infections
• Blood clots
• Infusion-related reactions
• Tumor lysis syndrome
• Pulmonary complications

Patients should immediately seek medical attention if they experience chest pain, severe breathing difficulty, persistent fever, unusual bleeding, swelling of the legs, or sudden weakness.

Precautions and Warnings

Before receiving Carfizome 60mg Injection, inform your healthcare provider if you have:

• Heart disease
• Kidney disease
• Liver disease
• High blood pressure
• Lung disorders
• Active infections
• History of blood clots

Women should avoid becoming pregnant during treatment. Effective contraception is recommended for both men and women throughout therapy and for the recommended period after treatment completion. Breastfeeding should be avoided while receiving Carfilzomib.

Storage Information

Carfizome 60mg Injection should be stored at 2°C to 8°C in a refrigerator and protected from light. Do not freeze the vial. The medicine should only be reconstituted immediately before use by trained healthcare professionals. Any unused solution should be discarded according to hospital safety protocols.

Why Buy Carfizome 60mg Injection from MedicineWalyDost?

At MedicineWalyDost, we are committed to supplying genuine oncology medicines sourced from trusted manufacturers. Carfizome 60mg Injection by Intas Pharmaceuticals is available with reliable delivery across Pakistan for patients, hospitals, and oncology clinics.

When you order from MedicineWalyDost, you benefit from:

• Genuine imported oncology medicines
• Competitive prices
• Nationwide delivery across Pakistan
• Secure packaging for temperature-sensitive medicines
• Professional customer support
• Assistance with medicine availability and ordering

Note: A valid prescription from a qualified oncologist is required before purchasing Carfizome 60mg Injection.

---

Frequently Asked Questions (FAQs)

What is Carfizome 60mg Injection used for?

Carfizome 60mg Injection is used for the treatment of relapsed or refractory multiple myeloma in adults, either alone or in combination with other anti-cancer medicines.

What does each pack contain?

Each pack contains 1 vial of Carfizome 60mg Injection manufactured by Intas Pharmaceuticals Ltd.

How is Carfizome administered?

It is given as an intravenous infusion by trained healthcare professionals in a hospital or oncology clinic.

Can Carfizome cure multiple myeloma?

Carfizome is not considered a cure for multiple myeloma, but it helps control disease progression, improves treatment response, and may extend progression-free survival in eligible patients.

Is a prescription required?

Yes. Carfizome 60mg Injection is a prescription-only oncology medicine and should only be used under the supervision of a qualified oncologist.